Urocit-K tablets modified-release

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

potassium citrate

Available from:

Mission Pharmacal Company

ATC code:

առկա չէ (G04BC)

INN (International Name):

potassium citrate

Dosage:

1080mg

Pharmaceutical form:

tablets modified-release

Units in package:

(100) in plastic container

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-08-08

Summary of Product characteristics

f,+
I
slc,s},l0fft
0F
pRE$CAffi
;t!{c
Jt\:r0R}rtATIot{
'fhcsc
iigbtighrs
do
not
incltrdc
rtt
the
informarion
trsded
to
xse
t"Jrocit--K
srfcly
rBd
ettsctirctr-y,6sr:
full
$fssr:ribin&
furforfitn$dn
f{}r
Urocif'-I(
Urftif-K
lps(Istfum
fitrlte)
Srt(ndcd-rrrrasc
tAbler,
for
orsl
use
Iritial
U,$.
Approvel:
lgtt5
*.NBCSKT
MAJOR
Ct
IANGES-.
Dasage
a*d
Adrniniraation,
Uro*ir+-K
l5
rnl:q (2.?,
2.i)
l?nrftl
Dosage
Forms-
ond
Strcngths,
Urocire-K
t
s
rnEq
flj
tuzgOS
Dcscriprioq
Urocirs-K
15
urEq
(I
l)
irizoos
Clinic.rf
SrurJies
(t4)
"
'
iUZOOy
HowSuppticd/*tomgeandHrnilting,Uuwits-K15nEq(161
t*ZaA*
::--:;:-**-**--tNtlrcATroNS
AND
IrSA(;E-__--
UrocitnK
is
s
ciratc
salt
ofpots$sium
indicated
lbr
rhc
nranrpcnrenl
of:
-
Renal
rubular
rcirJosis
iRTA)
with
crlcium
srones
(l.l
)
'
Hlpocirraturic
calciunr
oxalate
nephrolithiasis
ofany
eriology
(
1.3)
'
Uric
acid
lithiasis
with
nr
wirhout
calcium
stonus
(1.3)
--*-****"*IloSAGn
*r{I}
ADit
INI$TIIATION
Objective:
To
rcstorc
toflnal
urinary
ejtra(e
(greoler
ihan
310
rug/d^ry
and
as
close
torhe
nonnal
ltean
of
640
mlyday
as
possible),
and
to
incicasi
urinary
pll
to
a
level
of6.0
to
?.0.
'
Sevcrc
lrypyi$aturia
(ilrinary
cr0rte
<
t
j0
mgdsy):
rhcrapy
should
be
rilharcd
at
60
elrq
pcrday:
a
dosc
of
30
nrEr; nr.o
tirucs
per
day
or
20
nlLq
u)ree
onrcs
pcr
ddy
with
ucdls
or
within
30 rnjnutcs
ofter
meals
ur
bedtime
snack
{Z^?}
'
Yild.lo.rn$Iore
hySocirroruria
{*rinary
citrat€
>t
S0
mgldry):
thtrr{py
shculd
be iniriared
at
30
nrEq
per
day;
a
dose
of
I
5
mEq-two
iimes
pcr
day
or
l0
ulEq
tlree
times per
day
wit
r meals
or
rvithirr'J0
nrinltm
aflcr
nuats
or bedrime
snack
(2"3)
--***.-,..*-lls.sn$E
roRM$
af{b
sTRElti0TIIS
Tablcts:
5
nEqi
I
0
nrEq
aird
tf
mEq
{3}
COTYTR*I
NI}IC/rTI0NS*-***
'
Potieuts
with
hyperkalernia
(or
who
havc
conclirions
prcdisposinn
riem
to hlaerkalemir).
Such
condirions
inclsde
chrcnic
rcnal
l.ailun,'
uneonboJled
diahctes
mcllitu$r
acute
dehyelration.
strcnuous
rrhysical
exercise
ia unconditioned
individuals,
adrenal
irrsufficiency,
exielsiue
ti*sue
breahdorvn
{4}
'
Patic